QYUNS-B (02509) repurchased 44,000 shares for HKD 988,000 on January 21st.
Champion RealBiotech Group Ltd. (02509) announced that on January 21, 2026, the company spent HK$988,800 to repurchase 44,000 shares at a repurchase price of HK$22.08-22.50 per share.
QYUNS-B (02509) announces that on January 21, 2026, the company spent 988,800 Hong Kong dollars to repurchase 44,000 shares at a price of 22.08-22.50 Hong Kong dollars per share.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


